Back

Cerebellar tissue properties alterations in fibromyalgia: a T1w/T2w ratio study

Quide, Y.; Gustin, S. M.

2025-04-20 rheumatology
10.1101/2025.04.17.25326040
Show abstract

Fibromyalgia is associated with elevated levels of comorbid anxiety and depression, together impacting brain morphology possibly reflecting common underlying biological processes. The present study aims to determine the difference in regional myelination in females with fibromyalgia compared to females who do not experience chronic pain and determine the role of the severity of comorbid anxiety and depressive symptoms experienced to mediate this difference in brain myelination. Thirty-three females with and 33 females without (Controls) fibromyalgia were included, for which the severity of depressive and anxiety symptoms were recorded using the Hamilton Anxiety/Depression Rating scales (HAMA/HAMD). Whole-brain three-dimensional T1-weighted (T1w) and T2-weighted (T2w) magnetic resonance imaging scans were collected, and T1w/T2w ratio (myelin maps) derived. Mediation analyses were performed with anxiety and depressive symptoms as mediators of the T1w/T2w ratio differences among the groups. Compared to the control group, the fibromyalgia group lower T1w/T2w values in the left cerebellar lobule VI (pFWEc=0.030) and left cerebellar lobule VIII (pFWEc=0.029). These T1w/T2w values were significantly negatively associated with severity of anxiety and depressive symptoms (all p<0.001). Mediation analyses indicated that the severity of anxiety (but not depressive) symptoms mediated the group difference in T1w/T2w values in cerebellar lobule VI (p=0.012), but not VIII (p=0.813). Lowered cerebellar myelination may reflect chronic states of low-grade inflammation, resulting from the long-term consequences of living with fibromyalgia and related anxiety and depressive symptoms. This remains speculative, and future studies integrating peripheral biological markers of inflammation are warranted to confirm this interpretation.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Arthritis & Rheumatology
based on 21 papers
Top 0.2%
22.0%
2
Rheumatology
based on 21 papers
Top 0.4%
9.1%
3
PLOS ONE
based on 1737 papers
Top 54%
8.3%
4
Pain
based on 15 papers
Top 0.5%
5.0%
5
European Journal of Neuroscience
based on 10 papers
Top 0.1%
4.3%
6
Scientific Reports
based on 701 papers
Top 48%
3.1%
50% of probability mass above
7
RMD Open
based on 11 papers
Top 0.4%
2.7%
8
Frontiers in Immunology
based on 140 papers
Top 3%
2.7%
9
Metabolites
based on 10 papers
Top 0.3%
2.6%
10
Annals of the Rheumatic Diseases
based on 23 papers
Top 0.7%
2.5%
11
JCI Insight
based on 63 papers
Top 3%
2.5%
12
Translational Psychiatry
based on 94 papers
Top 5%
2.0%
13
Clinical Immunology
based on 12 papers
Top 0.7%
1.5%
14
Journal of Affective Disorders
based on 72 papers
Top 4%
1.5%
15
Journal of Personalized Medicine
based on 17 papers
Top 0.8%
1.5%
16
JAMA Network Open
based on 125 papers
Top 12%
1.5%
17
Frontiers in Genetics
based on 32 papers
Top 3%
1.5%
18
Biomedicines
based on 21 papers
Top 1%
1.5%
19
Human Genetics and Genomics Advances
based on 39 papers
Top 2%
1.3%
20
Brain, Behavior, and Immunity
based on 35 papers
Top 3%
0.9%
21
Frontiers in Psychiatry
based on 56 papers
Top 8%
0.7%
22
Journal of Clinical Medicine
based on 77 papers
Top 16%
0.7%
23
Biological Psychiatry Global Open Science
based on 23 papers
Top 3%
0.7%
24
Clinical Epigenetics
based on 21 papers
Top 2%
0.7%
25
Brain Communications
based on 79 papers
Top 7%
0.7%
26
Nature Communications
based on 483 papers
Top 42%
0.7%
27
Molecular Psychiatry
based on 84 papers
Top 6%
0.7%
28
International Journal of Molecular Sciences
based on 39 papers
Top 4%
0.7%
29
Frontiers in Human Neuroscience
based on 11 papers
Top 1%
0.7%